These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 31279884)

  • 1. Carboxypeptidase A4 promotes cell growth via activating STAT3 and ERK signaling pathways and predicts a poor prognosis in colorectal cancer.
    Pan H; Pan J; Ji L; Song S; Lv H; Yang Z; Guo Y
    Int J Biol Macromol; 2019 Oct; 138():125-134. PubMed ID: 31279884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Granulin epithelin precursor promotes colorectal carcinogenesis by activating MARK/ERK pathway.
    Pan Y; Cheung ST; Tong JHM; Tin KY; Kang W; Lung RWM; Wu F; Li H; Ng SSM; Mak TWC; To KF; Chan AWH
    J Transl Med; 2018 Jun; 16(1):150. PubMed ID: 29866109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carboxypeptidase A4 promotes proliferation and stem cell characteristics of hepatocellular carcinoma.
    Zhang H; Hao C; Wang H; Shang H; Li Z
    Int J Exp Pathol; 2019 Apr; 100(2):133-138. PubMed ID: 31058377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EXOSC5 as a Novel Prognostic Marker Promotes Proliferation of Colorectal Cancer via Activating the ERK and AKT Pathways.
    Pan H; Pan J; Song S; Ji L; Lv H; Yang Z
    Front Oncol; 2019; 9():643. PubMed ID: 31380280
    [No Abstract]   [Full Text] [Related]  

  • 5. Carboxypeptidase A4 negatively correlates with p53 expression and regulates the stemness of breast cancer cells.
    Wang Y; Xie Y; Niu Y; Song P; Liu Y; Burnett J; Yang Z; Sun D; Ran Y; Li Y; Sun L
    Int J Med Sci; 2021; 18(8):1753-1759. PubMed ID: 33746592
    [No Abstract]   [Full Text] [Related]  

  • 6. Carboxypeptidase A4 accumulation is associated with an aggressive phenotype and poor prognosis in triple-negative breast cancer.
    Handa T; Katayama A; Yokobori T; Yamane A; Fujii T; Obayashi S; Kurozumi S; Kawabata-Iwakawa R; Gombodorj N; Nishiyama M; Asao T; Shirabe K; Kuwano H; Oyama T
    Int J Oncol; 2019 Mar; 54(3):833-844. PubMed ID: 30628666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Downregulation of CPA4 inhibits non small-cell lung cancer growth by suppressing the AKT/c-MYC pathway.
    Fu Y; Su L; Cai M; Yao B; Xiao S; He Q; Xu L; Yang L; Zhao C; Wan T; Shao L; Wang L; Huang X
    Mol Carcinog; 2019 Nov; 58(11):2026-2039. PubMed ID: 31397502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The overexpression of AUF1 in colorectal cancer predicts a poor prognosis and promotes cancer progression by activating ERK and AKT pathways.
    Tian XY; Li J; Liu TH; Li DN; Wang JJ; Zhang H; Deng ZL; Chen FJ; Cai JP
    Cancer Med; 2020 Nov; 9(22):8612-8623. PubMed ID: 33016643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. STIP1 knockdown suppresses colorectal cancer cell proliferation, migration and invasion by inhibiting STAT3 pathway.
    Xia Y; Chen J; Liu G; Huang W; Wei X; Wei Z; He Y
    Chem Biol Interact; 2021 May; 341():109446. PubMed ID: 33766539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Knockdown of carboxypeptidase A4 (
    Lei X; Liu D; Song D; Fan J; Dai G; Yang L
    J Gastrointest Oncol; 2022 Dec; 13(6):2823-2831. PubMed ID: 36636089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-145-5p restrained cell growth, invasion, migration and tumorigenesis via modulating RHBDD1 in colorectal cancer via the EGFR-associated signaling pathway.
    Niu Y; Zhang J; Tong Y; Li J; Liu B
    Int J Biochem Cell Biol; 2019 Dec; 117():105641. PubMed ID: 31693935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PDCD6 cooperates with C-Raf to facilitate colorectal cancer progression via Raf/MEK/ERK activation.
    Wang X; Wu F; Wang H; Duan X; Huang R; Tuersuntuoheti A; Su L; Yan S; Zhao Y; Lu Y; Li K; Yao J; Luo Z; Guo L; Liu J; Chen X; Lu Y; Hu H; Li X; Bao M; Bi X; Du B; Miao S; Cai J; Wang L; Zhou H; Ying J; Song W; Zhao H
    J Exp Clin Cancer Res; 2020 Aug; 39(1):147. PubMed ID: 32746883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum carboxypeptidaseA4 levels predict liver metastasis in colorectal carcinoma.
    Sun L; Guo C; Burnett J; Yang Z; Ran Y; Sun D
    Oncotarget; 2016 Nov; 7(48):78688-78697. PubMed ID: 27780921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The inhibition effects of apatinib on cell proliferation, migration and apoptosis in esophageal carcinoma via Ras/Raf/MEK/ERK and JAK2/STAT3 pathways].
    Feng Y; Zhou MY; Sun F; Kong Z; Wang J; Sun ZQ; Hu LJ; Wang JL; Hua Q; Yu JP
    Zhonghua Zhong Liu Za Zhi; 2019 Apr; 41(4):263-275. PubMed ID: 31014051
    [No Abstract]   [Full Text] [Related]  

  • 15. Identification of NCK1 as a novel downstream effector of STAT3 in colorectal cancer metastasis and angiogenesis.
    Zhang F; Lu YX; Chen Q; Zou HM; Zhang JM; Hu YH; Li XM; Zhang WJ; Zhang W; Lin C; Li XN
    Cell Signal; 2017 Aug; 36():67-78. PubMed ID: 28455144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carboxypeptidase A4 promotes cardiomyocyte hypertrophy through activating PI3K-AKT-mTOR signaling.
    Gao W; Guo N; Zhao S; Chen Z; Zhang W; Yan F; Liao H; Chi K
    Biosci Rep; 2020 May; 40(5):. PubMed ID: 32347291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-346-5p promotes colorectal cancer cell proliferation in vitro and in vivo by targeting FBXL2 and activating the β-catenin signaling pathway.
    Pan S; Wu W; Ren F; Li L; Li Y; Li W; Wang A; Liu D; Dong Y
    Life Sci; 2020 Mar; 244():117300. PubMed ID: 31953162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LncRNA AB073614 regulates proliferation and metastasis of colorectal cancer cells via the PI3K/AKT signaling pathway.
    Wang Y; Kuang H; Xue J; Liao L; Yin F; Zhou X
    Biomed Pharmacother; 2017 Sep; 93():1230-1237. PubMed ID: 28738539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The HOTAIR/miR-214/ST6GAL1 crosstalk modulates colorectal cancer procession through mediating sialylated c-Met via JAK2/STAT3 cascade.
    Liu B; Liu Q; Pan S; Huang Y; Qi Y; Li S; Xiao Y; Jia L
    J Exp Clin Cancer Res; 2019 Nov; 38(1):455. PubMed ID: 31694696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. microRNA-7 is a novel inhibitor of YY1 contributing to colorectal tumorigenesis.
    Zhang N; Li X; Wu CW; Dong Y; Cai M; Mok MT; Wang H; Chen J; Ng SS; Chen M; Sung JJ; Yu J
    Oncogene; 2013 Oct; 32(42):5078-88. PubMed ID: 23208495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.